This Article  • References  • Full text PDF  • Correction  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

The Framington Study

Tavia Gordon; William P. Castelli, MD; Marthana C. Hjortland, PhD; William B. Kannel, MD; Thomas R. Dawber, MD

JAMA. 1977;238(6):497-499.

Abstract
Of 1,025 men and 1,445 women, aged 49 to 82 years, who were free of coronary heart disease (CHD), 79 men and 63 women subsequently had CHD. Using a risk function based on cholesterol in the high density and low density lipoproteins, systolic blood pressure, left ventricular hypertrophy, and diabetes, less than 2% of the subsequent CHD cases were found in the lowest decile of risk, whereas 25% of the cases for men and 37% for women were found in the highest decile. Predictability held for each specific age group. This predictability was at least as good as that obtained by the usual CHD risk profile at younger ages.

(JAMA 238:497-499, 1977)

Author Affiliations
From the National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Md (Mr Gordon and Drs Castelli, Hjortland, and Kannel), and Boston University Medical School, Boston (Dr Dawber).

Footnotes
Reprint requests to Biometrics Research Branch, National Heart, Lung, and Blood Institute, Bethesda, MD 20014 (Mr Gordon).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The Framingham Predictive Instrument in Chronic Kidney Disease
Weiner et al.
J Am Coll Cardiol 2007;50:217-224.
ABSTRACT | FULL TEXT  

Microalbuminuria is independently associated with ischaemic electrocardiographic abnormalities in a large non-diabetic population. The PREVEND (Prevention of REnal and Vascular ENdstage Disease) study
Diercks et al.
Eur Heart J 2000;21:1922-1927.
ABSTRACT  

Mortality from all causes and from coronary heart disease related to smoking and changes in smoking during a 35-year follow-up of middle-aged Finnish men
Qiao et al.
Eur Heart J 2000;21:1621-1626.
ABSTRACT  

Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects
Duchateau et al.
J. Lipid Res. 2000;41:1231-1236.
ABSTRACT | FULL TEXT  

Cholesterol Lowering in the Elderly Population
Grundy et al.
Arch Intern Med 1999;159:1670-1678.
ABSTRACT | FULL TEXT  

Primary Prevention of Coronary Heart Disease: Guidance From Framingham : A Statement for Healthcare Professionals From the AHA Task Force on Risk Reduction
Grundy et al.
Circulation 1998;97:1876-1887.
FULL TEXT  

Apolipoprotein L, a New Human High Density Lipoprotein Apolipoprotein Expressed by the Pancreas. IDENTIFICATION, CLONING, CHARACTERIZATION, AND PLASMA DISTRIBUTION OF APOLIPOPROTEIN L
Duchateau et al.
J. Biol. Chem. 1997;272:25576-25582.
ABSTRACT | FULL TEXT  

Cumulative Effects of High Cholesterol Levels, High Blood Pressure, and Cigarette Smoking on Carotid Stenosis
Wilson et al.
NEJM 1997;337:516-522.
ABSTRACT | FULL TEXT  

Association of Body Mass Index With Blood Pressure in Elderly Japanese American Men: The Honolulu Heart Program
Masaki et al.
Hypertension 1997;29:673-677.
ABSTRACT | FULL TEXT  

Serum Lipids and Incidence of Coronary Heart Disease: Findings From the Systolic Hypertension in the Elderly Program (SHEP)
Frost et al.
Circulation 1996;94:2381-2388.
ABSTRACT | FULL TEXT  

Coronary Heart Disease Risk Factors in Men and Women Aged 60 Years and Older : Findings From the Systolic Hypertension in the Elderly Program
Frost et al.
Circulation 1996;94:26-34.
ABSTRACT | FULL TEXT  

Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma
Lagrost et al.
Arterioscler. Thromb. Vasc. Bio. 1995;15:1388-1396.
ABSTRACT | FULL TEXT  

Lifestyle and Biologic Factors Associated With Atherosclerotic Disease in Middle-aged Men: 20-Year Findings From the Honolulu Heart Program
Goldberg et al.
Arch Intern Med 1995;155:686-694.
ABSTRACT  

Costs and Health Consequences of Cholesterol Screening for Asymptomatic Older Americans
Garber et al.
Arch Intern Med 1991;151:1089-1095.
ABSTRACT  

High Blood Cholesterol in Elderly Men and the Excess Risk for Coronary Heart Disease
Rubin et al.
ANN INTERN MED 1990;113:916-920.
ABSTRACT  

Treatment of Hypercholesterolemia in the Elderly
Kafonek and Kwiterovich
ANN INTERN MED 1990;112:723-725.
ABSTRACT  

Hypercholesterolemia in Elderly Persons: Resolving the Treatment Dilemma
Denke and Grundy
ANN INTERN MED 1990;112:780-792.
ABSTRACT  

Body Weight as a Risk Factor in the Elderly
Tayback et al.
Arch Intern Med 1990;150:1065-1072.
ABSTRACT  

Is Elevated Serum Cholesterol Level a Risk Factor for Coronary Heart Disease in the Elderly?
Benfante and Reed
JAMA 1990;263:393-396.
ABSTRACT  

Effects of a Low Saturated Fat, Low Cholesterol Fish Oil Supplement in Hypertriglyceridemic Patients: A Placebo-Controlled Trial
Harris et al.
ANN INTERN MED 1988;109:465-470.
ABSTRACT  

Smoking and Coronary Heart Disease Mortality in the Elderly
Jajich et al.
JAMA 1984;252:2831-2834.
ABSTRACT  

Changes in Plasma Cholesterol and Triglyceride Levels After Treatment With Oral Isotretinoin: A Prospective Study
Zech et al.
Arch Dermatol 1983;119:987-993.
ABSTRACT  

Elevation of Serum Triglyceride Levels From Oral Isotretinoin in Disorders of Keratinization
Katz et al.
Arch Dermatol 1980;116:1369-1372.
ABSTRACT